US$ 27.34
glp-1 receptor agonists mechanism of action GLP1 Frontiers | Mechanisms of action
Description
However, these molecular mechanisms need to be further elucidated ( 2 The AMPK pathway AMPK is a serine/threonine kinase comprised of a catalytic alpha subunit and two subunits of beta and gamma regulators ( 3 The relationship between AMPK and antidiabetic drugs Metformin, the most widely used oral agent for the treatment of T2D, is historically known as an AMPK activator ( 3.1 SGLT2i and AMPK The SGLT2i (Sodium-glucose co-transport 2 inhibitors) are a class of antidiabetic agents, targeting the major glucose transporter SGLT2 in the kidney

Janzen KM, Steuber TD, Nisly SA

By increasing Ca 2+ influx and consequently insulin granule exocytosis, both pathways work together to promote insulin secretion

doi: 10.1016/j.yhbeh.2019.104640 243 GejlMGjeddeAEgefjordLMollerAHansenSBVangKet al
